Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)
- PMID: 23933536
- DOI: 10.1016/j.jacc.2013.07.030
Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)
Comment in
-
Clinical implication landmark: noninvasive quantification of fractional flow reserve evaluating interventional therapy.Catheter Cardiovasc Interv. 2014 Feb;83(2):334-5. doi: 10.1002/ccd.25195. Catheter Cardiovasc Interv. 2014. PMID: 24030854 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
